Orange Grove Bio

About:

Orange Grove Bio (“OGB”) is a preclinical drug investment and development platform.

Website: https://www.orangegrovebio.com/

Top Investors: Small Business Innovation Research, THE CATALYTIC IMPACT FOUNDATION (CIF)

Description:

Orange Grove Bio (“OGB”) is a preclinical drug investment and development platform focused on driving down the cost of drug discovery and advancing therapies into clinical trials.

Total Funding Amount:

$23.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cincinnati, Ohio, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)orangegrovebio.com

Founders:

Marc Appel

Number of Employees:

11-50

Last Funding Date:

2024-04-24

IPO Status:

Private

Industries: